[Regression of xanthomas and hypolipidemic drugs].
D000328:Adult; D001161:Arteriosclerosis / Q000150:complications; D002784:Cholesterol / Q000097:blood; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002994:Clofibrate / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000235:genetics; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009255:Nafenopin / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood; D014973:Xanthomatosis / Q000188:drug therapy* / Q000209:etiology
D000960:Hypolipidemic Agents; D009539:Nicotinic Acids; D014280:Triglycerides; D009255:Nafenopin; D002792:Cholestyramine Resin; D002784:Cholesterol; D002994:Clofibrate
Regression de xanthomes et medicaments hypolipidemiants.